ALKERMES | Aktie



Stock Lave om Dato
AbbVie USD 4.18B 269M 2024-12
Acadia Pharmaceuticals USD 21.95M 39.09M 2024-12
ALKERMES USD 182.89M 8.2M 2024-12
Amgen USD 7B 364M 2024-12
Biogen USD 2.46B 8.7M 2024-12
BioMarin Pharmaceutical USD 1.23B 53.31M 2024-12
Bristol-Myers Squibb USD 2.56B 775M 2024-12
Eli Lilly USD 7.59B 129.4M 2024-12
Gilead Sciences USD 3.59B 154M 2024-12
Intra Cellular Therapies USD 26.28M 2.74M 2024-12
Ionis Pharmaceuticals USD 12.51M 15.94M 2024-12
J&J USD 12.44B 159M 2024-12
Merck USD 6.11B 135M 2024-12
Neurocrine Biosciences USD 57.4M 11.6M 2024-12
Otsuka Holdings JPY 298.29B 8.91B 2024-12
Pfizer USD 10.85B 870M 2024-12
Regeneron Pharmaceuticals USD 3.09B 69.3M 2024-12
Vertex Pharmaceuticals USD 1.21B 125.6M 2024-12



ALKERMES Aktie - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.